Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Eagle Pharmaceuticals completes NDA submission for Ryanodex

Jan. 24, 2017

AnaMar reports 5-HT2B receptor antagonists

Jan. 17, 2017

AdAlta reports additional preclinical data for AD-114 in lung and liver fibrosis

Jan. 11, 2017

Mutations in FAM105B gene may be involved in autoinflammatory diseases

Nov. 29, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

Nov. 14, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis

Aug. 19, 2016

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...